Using Neisseria meningitidis genomic diversity to inform outbreak strain identification.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
05 2021
Historique:
received: 24 12 2020
accepted: 26 04 2021
revised: 04 06 2021
pubmed: 19 5 2021
medline: 13 10 2021
entrez: 18 5 2021
Statut: epublish

Résumé

Meningococcal disease is a life-threatening illness caused by the human-restricted bacterium Neisseria meningitidis. Outbreaks in the USA involve at least two cases in an organization or community caused by the same serogroup within three months. Genome comparisons, including phylogenetic analysis and quantification of genome distances can provide confirmatory evidence of pathogen transmission during an outbreak. Interpreting genome distances depends on understanding their distribution both among isolates from outbreaks and among those not from outbreaks. Here, we identify outbreak strains based on phylogenetic relationships among 141 N. meningitidis isolates collected from 28 outbreaks in the USA during 2010-2017 and 1516 non-outbreak isolates collected through contemporaneous meningococcal surveillance. We show that genome distance thresholds based on the maximum SNPs and allele distances among isolates in the phylogenetically defined outbreak strains are sufficient to separate most pairs of non-outbreak isolates into separate strains. Non-outbreak isolate pairs that could not be distinguished from each other based on genetic distances were concentrated in the clonal complexes CC11, CC103, and CC32. Within each of these clonal complexes, phylodynamic analysis identified a group of isolates with extremely low diversity, collected over several years and multiple states. Clusters of isolates with low genetic diversity could indicate increased pathogen transmission, potentially resulting in local outbreaks or nationwide clonal expansions.

Identifiants

pubmed: 34003852
doi: 10.1371/journal.ppat.1009586
pii: PPATHOGENS-D-20-02756
pmc: PMC8177650
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009586

Déclaration de conflit d'intérêts

L.H.H. has served as a consultant for GSK, Sanofi Pasteur, Pfizer, and Merck in the area of epidemiology and vaccine prevention of bacterial diseases. The other authors have declared that no competing interests exist.

Références

Appl Environ Microbiol. 2016 May 31;82(12):3582-3590
pubmed: 27060122
Mol Ecol Resour. 2017 Jan;17(1):96-100
pubmed: 27801980
Nat Microbiol. 2016 Oct 10;2:16185
pubmed: 27723724
J Infect Dis. 2020 Nov 9;222(11):1816-1825
pubmed: 32163580
J Clin Microbiol. 2001 Jan;39(1):75-85
pubmed: 11136752
Nat Rev Microbiol. 2020 Feb;18(2):84-96
pubmed: 31705134
Wellcome Open Res. 2018 Sep 24;3:124
pubmed: 30345391
Euro Surveill. 2020 Jun;24(23):
pubmed: 31186079
Euro Surveill. 2016 Nov 10;21(45):
pubmed: 27918265
Bioinformatics. 2009 Jun 1;25(11):1422-3
pubmed: 19304878
Clin Infect Dis. 2019 Feb 1;68(4):580-585
pubmed: 29982382
Ther Adv Vaccines. 2014 May;2(3):71-6
pubmed: 24790731
Genome Res. 2019 Feb;29(2):304-316
pubmed: 30679308
J Infect Dis. 2020 Oct 27;:
pubmed: 33107578
Front Microbiol. 2019 Dec 18;10:2897
pubmed: 31921072
J R Soc Interface. 2014 Dec 6;11(101):20140945
pubmed: 25401173
Clin Microbiol Infect. 2019 Jan;25(1):111.e1-111.e4
pubmed: 30036673
J Infect. 2019 Nov;79(5):426-434
pubmed: 31505201
Lancet Microbe. 2020 Dec;1(8):e328-e335
pubmed: 33313577
Sci Rep. 2018 Oct 25;8(1):15803
pubmed: 30361650
Nat Methods. 2020 Mar;17(3):261-272
pubmed: 32015543
Emerg Infect Dis. 2019 Mar;25(3):434-440
pubmed: 30789140
FEMS Microbiol Rev. 2007 Jan;31(1):89-96
pubmed: 17168996
Bioinformatics. 2019 Nov 1;35(21):4453-4455
pubmed: 31070718
Emerg Infect Dis. 2015 Sep;21(9):1520-8
pubmed: 26292067
Syst Biol. 2020 Sep 1;69(5):884-896
pubmed: 32049340
Front Genet. 2020 Dec 07;11:579411
pubmed: 33365047
J Clin Microbiol. 2021 Feb 18;59(3):
pubmed: 33328176
Emerg Infect Dis. 2016 Oct;22(10):1762-1768
pubmed: 27649262
Clin Infect Dis. 2018 Apr 3;66(8):1276-1281
pubmed: 29126310
Front Microbiol. 2018 Jul 10;9:1482
pubmed: 30042741
J Clin Microbiol. 2019 Dec 23;58(1):
pubmed: 31666361
J Clin Microbiol. 2017 Jul;55(7):2086-2097
pubmed: 28446571
Nat Microbiol. 2020 Jul;5(7):876-877
pubmed: 32427978
J Infect. 2018 Nov;77(5):427-434
pubmed: 29964139
Bioinformatics. 2015 Sep 1;31(17):2877-8
pubmed: 25913206
PLoS One. 2018 Nov 28;13(11):e0202615
pubmed: 30485280
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349

Auteurs

Adam C Retchless (AC)

Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Alex Chen (A)

Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

How-Yi Chang (HY)

Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Amy E Blain (AE)

Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Lucy A McNamara (LA)

Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Mustapha M Mustapha (MM)

Microbial Genomic Epidemiology Laboratory, Center for Genomic Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.

Lee H Harrison (LH)

Microbial Genomic Epidemiology Laboratory, Center for Genomic Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.

Xin Wang (X)

Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH